LFMD Key Statistics, Chart & Performance
The current stock price of LFMD is 3.5 USD. In the past month the price decreased by -8.85%. In the past year, price decreased by -32.95%.
LFMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 29.02 | 36.93B | ||
| DOCS | DOXIMITY INC-CLASS A | 26.64 | 8.23B | ||
| WAY | WAYSTAR HOLDING CORP | 24.61 | 6.31B | ||
| HTFL | HEARTFLOW INC | N/A | 2.54B | ||
| CERT | CERTARA INC | 17.78 | 1.42B | ||
| SDGR | SCHRODINGER INC | N/A | 1.35B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.26B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 636.75 | 1.08B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.03B | ||
| PHR | PHREESIA INC | N/A | 1.02B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 7.86 | 933.43M | ||
| HSTM | HEALTHSTREAM INC | 34.72 | 700.51M |
Related stock screener links
About LFMD
Company Profile
LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The company is headquartered in New York City, New York and currently employs 304 full-time employees. The company went IPO on 2001-07-11. The firm offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The firm owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.
Company Info
LIFEMD INC
236 Fifth Avenue, Suite 400
New York City NEW YORK 10022 US
CEO: Justin Schreiber
Employees: 306
Phone: 18663515907
LIFEMD INC / LFMD FAQ
What does LIFEMD INC do?
LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The company is headquartered in New York City, New York and currently employs 304 full-time employees. The company went IPO on 2001-07-11. The firm offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The firm owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.
What is the stock price of LIFEMD INC today?
The current stock price of LFMD is 3.5 USD. The price decreased by -12.5% in the last trading session.
Does LFMD stock pay dividends?
LFMD does not pay a dividend.
How is the ChartMill rating for LIFEMD INC?
LFMD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Is LIFEMD INC (LFMD) expected to grow?
The Revenue of LIFEMD INC (LFMD) is expected to grow by 15.11% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the employee count for LFMD stock?
LIFEMD INC (LFMD) currently has 306 employees.
Can you provide the short interest for LFMD stock?
The outstanding short interest for LIFEMD INC (LFMD) is 12.3% of its float.
LFMD Technical Analysis
LFMD Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to LFMD. LFMD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
LFMD Financial Highlights
Over the last trailing twelve months LFMD reported a non-GAAP Earnings per Share(EPS) of -0.14. The EPS increased by 78.13% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -11.68% | ||
| ROE | -586.53% | ||
| Debt/Equity | 0 |
LFMD Forecast & Estimates
14 analysts have analysed LFMD and the average price target is 9.44 USD. This implies a price increase of 169.57% is expected in the next year compared to the current price of 3.5.
For the next year, analysts expect an EPS growth of 61.09% and a revenue growth 15.11% for LFMD